CCDM Study Guide Brilliant CCDM Exam Dumps PDF
View CCDM Exam Question Dumps With Latest Demo
NEW QUESTION # 75
Which of the following processes is the most likely to remain in a study that utilizes electronic data capture?
- A. Resolving queries
- B. Updating the in-house database
- C. Tracking case report forms
- D. Retrieving case report forms
Answer: A
Explanation:
In studies utilizing Electronic Data Capture (EDC) systems, many traditional paper-based processes such as tracking and retrieving CRFs are eliminated or automated. However, query management and resolution remain essential because discrepancies, missing data, and protocol deviations still require clarification and correction, regardless of the data collection medium.
According to the GCDMP (Chapter: Data Validation and Cleaning), data queries are generated automatically or manually when inconsistencies are detected by edit checks. Sites must still respond to these queries electronically to ensure the integrity and completeness of data.
A and D are obsolete with EDC (no physical CRFs).
B refers to manual data entry updates, which are replaced by direct EDC entry.
C (Resolving queries) continues as a key part of the data management workflow, even in fully electronic environments.
Thus, option C is correct.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 5.4 - Query Generation and Resolution in EDC Systems ICH E6(R2) GCP, Section 5.5.3 - Data Review and Query Resolution Requirements FDA 21 CFR Part 11 - Electronic Records: Audit Trails and Query Documentation C
NEW QUESTION # 76
Which method would best identify inaccuracies in safety data tables for an NDA?
- A. Compare counts of appropriate patients from manual CRFs to counts in table cells
- B. Review the line listings to identify any values that look odd
- C. Review the tables to identify any values that look odd
- D. Compare counts of appropriate patients from line listings of CRF data to counts in table cells
Answer: D
Explanation:
The best method for identifying inaccuracies in safety data tables prepared for a New Drug Application (NDA) is to compare counts of appropriate patients from line listings of CRF data to the counts in table cells.
According to the GCDMP (Chapter: Data Quality Assurance and Control), line listings represent raw, patient-level data extracted directly from the clinical database, whereas summary tables are aggregated outputs used for reporting and submission. Comparing these two sources ensures data traceability and accuracy, verifying that tabulated results correctly reflect the underlying patient data.
Manual CRF checks (option A) are less efficient and error-prone, as data entry is typically already validated electronically. Simply reviewing tables or listings for "odd values" (options C and D) lacks the systematic verification necessary for regulatory data integrity.
Thus, comparing line listings to tables (option B) provides a quantitative cross-check between the database and output deliverables, a standard practice in NDA data validation and statistical quality control.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 5.2 - Validation of Tables, Listings, and Figures (TLFs) FDA Guidance for Industry: Submission of NDA Safety Data, Section on Data Verification and Accuracy ICH E6 (R2) GCP, Section 5.5.3 - Validation of Derived Data Outputs
NEW QUESTION # 77
What does 21 CFR Part 11 dictate in regards to a minimum expectation of EDC training prior to access?
- A. Training must be face to face
- B. Training must be performed
- C. Training must be in the user's native language
- D. Training must include an exam
Answer: B
Explanation:
Under FDA 21 CFR Part 11, organizations using electronic systems must ensure that all system users are trained to perform their assigned functions before gaining access to the system. The regulation requires documented evidence of training but does not specify how it should be conducted (e.g., exam-based, in person, or language-specific).
The GCDMP (Chapter: Computerized Systems and Compliance) further clarifies that personnel training should include instruction on system functionality, audit trails, data entry procedures, and electronic signatures to maintain compliance and data integrity. Training must be performed and documented but does not require a specific format or delivery method.
Therefore, option A-Training must be performed-is correct, as it reflects the minimum regulatory expectation per FDA and SCDM standards.
Reference (CCDM-Verified Sources):
FDA 21 CFR Part 11, Section 11.10(i) - Personnel Training Requirements
SCDM GCDMP, Chapter: Computerized Systems and Compliance, Section 5.4 - System Training and Documentation ICH E6(R2) GCP, Section 2.8 - Qualified Personnel and Training Requirements
NEW QUESTION # 78
In an EDC study, an example of an edit check that would be inefficient to run at data entry is a check:
- A. Against a valid list of values.
- B. Against a valid numeric range.
- C. On the format of a date.
- D. Across visits for consistency.
Answer: D
Explanation:
In Electronic Data Capture (EDC) systems, edit checks are categorized based on when and how they are executed - typically immediate (at data entry) or batch (post-entry). Checks that require data from multiple visits or forms are generally inefficient to run at data entry because they depend on information that may not yet exist in the system.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Data Validation and Cleaning), cross-visit consistency checks - such as comparing baseline and follow-up blood pressure or verifying date order between screening and dosing - should be executed as batch or scheduled validations, not at the point of data entry. Running these complex checks in real time can slow system performance, increase query load unnecessarily, and confuse site users if related data are not yet entered.
Conversely, edit checks against valid ranges, formats, or predefined value lists (options A, C, and D) are simple, local validations ideally performed immediately at data entry to prevent basic errors.
Therefore, cross-visit consistency checks (Option B) are best executed later, making them inefficient for real-time data entry validation.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 6.4 - Real-Time vs. Batch Edit Checks FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Section on Edit Checks and Data Validation Logic CDISC SDTM Implementation Guide - Section on Temporal Data Consistency Validation
NEW QUESTION # 79
An international study collects lab values. Sites use different units in the source documents. Which of the following data collection strategies will have fewer transcription errors?
- A. Allow values to be entered as they are in the source document and derive the units based on the magnitude of the value
- B. Use a structured field and print standard units on the data collection form
- C. Have all sites convert the values to the same unit system on the data collection form
- D. Allow values to be entered as they are in the source and the selection of units on the data collection form
Answer: D
Explanation:
In international or multicenter clinical studies, laboratory data often originate from different laboratories that use varying measurement units (e.g., mg/dL vs. mmol/L). The Good Clinical Data Management Practices (GCDMP, Chapter on CRF Design and Data Collection) provides clear guidance on managing this variability to ensure data consistency, traceability, and minimized transcription errors.
The approach that results in fewer transcription errors is to allow sites to enter lab values exactly as recorded in the source document (original lab report) and to require explicit selection of the corresponding unit from a predefined list on the data collection form or within the electronic data capture (EDC) system. This method (Option B) preserves the original source data integrity while enabling centralized or automated unit conversion later during data cleaning or statistical processing.
Option B also supports compliance with ICH E6 (R2) Good Clinical Practice (GCP), which mandates that transcribed data must remain consistent with the source documents. Attempting to derive units automatically (Option A) can lead to logical errors, while forcing sites to manually convert units (Option D) introduces unnecessary complexity and increases the risk of miscalculation or inconsistent conversions. Printing only standard units on the CRF (Option C) ignores local lab practices and can lead to discrepancies between CRF entries and source records, triggering numerous data queries.
The GCDMP emphasizes that CRF design must account for local variations in measurement systems and ensure that unit selection is structured (dropdowns, controlled lists) rather than free-text to prevent typographical errors and facilitate standardization during data transformation.
Therefore, Option B-"Allow values to be entered as they are in the source and the selection of units on the data collection form"-is the most compliant, accurate, and efficient strategy for minimizing transcription errors in international lab data collection.
Reference (CCDM-Verified Sources):
Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: CRF Design and Data Collection, Section 5.4 - Laboratory Data Management and Unit Handling ICH E6 (R2) Good Clinical Practice, Section 5.18 - Data Handling and Record Retention CDISC SDTM Implementation Guide, Section 6.3 - Handling of Laboratory Data and Standardized Units FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6 - Source Data and Accuracy of Data Entry
NEW QUESTION # 80
In a study conducted using paper CRFs, a discrepancy is discovered in a CRF to database QC audit. What is the reason why this discrepancy would be considered an audit finding?
- A. Discrepancy not explained by the data handling conventions
- B. Discrepancy not explained by the CRF completion guidelines
- C. Discrepancy not explained by the data quality control audit plan
- D. Discrepancy not explained by the protocol
Answer: A
Explanation:
In a CRF-to-database quality control (QC) audit, auditors compare data recorded on the paper Case Report Form (CRF) with data entered in the electronic database. If discrepancies exist that cannot be explained by documented data handling conventions, they are classified as audit findings.
Per GCDMP (Chapter: Data Quality Assurance and Control), data handling conventions define acceptable data entry practices, transcription rules, and allowable transformations. These conventions ensure that CRF data are consistently interpreted and entered.
If a discrepancy deviates from these established rules, it indicates a process gap or error in data entry, validation, or training. Discrepancies justified by protocol design or CRF guidelines would not constitute findings.
Therefore, option C (Discrepancy not explained by the data handling conventions) correctly identifies the criterion for a true QC audit finding.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Quality Assurance and Control, Section 6.1 - Data Handling Conventions and QC Auditing ICH E6(R2) GCP, Section 5.1 - Quality Management and Documentation of Deviations FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.5 - Data Verification and Audit Findings
NEW QUESTION # 81
A Data Manager is designing a CRF for a study for which the efficacy data are not covered by the current SDTM domains. Which search should the Data Manager do?
- A. Search for relevant data element standards
- B. Use controlled terminology covering the needed concepts
- C. Work with the study team to define new data elements
- D. Advise the study team not to collect the data
Answer: A
Explanation:
When existing SDTM (Study Data Tabulation Model) domains do not cover specific efficacy data, the best practice is to first search for relevant data element standards that may be available through CDISC CDASH (Clinical Data Acquisition Standards Harmonization) or other recognized industry standards.
Per GCDMP (Chapter: Standards and Data Integration), Data Managers must ensure that new CRF elements are consistent with standardized definitions, controlled terminology, and data models to support interoperability, future analysis, and regulatory submission.
If no existing standards exist, only then should the Data Manager collaborate with the study team to define new elements - but standard searches always come first.
Thus, option C is correct - search for relevant data element standards ensures alignment with CDISC best practices and regulatory expectations.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Standards and Data Integration, Section 5.1 - Use of CDISC Standards in CRF Design CDISC CDASH Implementation Guide, Section 4.1 - Standardization of Data Collection Fields FDA Study Data Technical Conformance Guide (SDTCG), Section 2.4 - Use of Standard and Custom Domains
NEW QUESTION # 82
Which type of edit check would be implemented to check the correctness of data present in a text box?
- A. Programmed check
- B. Manual Check
- C. Front-end check
- D. Back-end check
Answer: C
Explanation:
A front-end check is a type of real-time validation performed at the point of data entry-typically within an Electronic Data Capture (EDC) system or data entry interface-designed to ensure that the data entered in a text box (or any input field) is valid, logically correct, and within expected parameters before the user can proceed or save the record.
According to the Good Clinical Data Management Practices (GCDMP, Chapter on Data Validation and Cleaning), edit checks are essential components of data validation that ensure data accuracy, consistency, and completeness. Front-end checks are implemented within the data collection interface and are triggered immediately when data are entered. They prevent invalid entries (such as letters in numeric fields, out-of-range values, or improper date formats) from being accepted by the system.
Examples of front-end checks include:
Ensuring a numeric field accepts only numbers (e.g., weight cannot include text characters).
Validating that a date is within an allowable range (e.g., not before the subject's date of birth).
Requiring mandatory fields to be completed before moving forward.
This differs from back-end checks or programmed checks, which are typically run later in batch processes to identify data inconsistencies after entry. Manual checks are human-performed reviews, often for context or data that cannot be validated automatically (e.g., narrative assessments).
Front-end edit checks are preferred wherever possible because they prevent errors at the source, reducing the number of downstream data queries and cleaning cycles. They contribute significantly to data quality assurance, regulatory compliance, and efficiency in data management operations.
Reference (CCDM-Verified Sources):
Society for Clinical Data Management (SCDM), Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 6.2 - Edit Checks and Real-Time Data Validation FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6 - Data Entry and Verification Controls ICH E6 (R2) Good Clinical Practice, Section 5.5 - Data Handling and Record Integrity CDISC Operational Data Model (ODM) Specification - Edit Check Implementation Standards
NEW QUESTION # 83
Which is the MOST appropriate flow for EDC set-up and implementation?
- A. CRF "wire-frames" created, CRFs reviewed, CRFs printed, CRFs distributed to sites
- B. Database created, Subjects enrolled, Database tested, Sites trained, Database released
- C. Protocol finalized, Database created, Edit Checks created, Database tested, Sites trained
- D. Database created, Database tested, Sites trained, Protocol finalized, Database released
Answer: C
Explanation:
The correct and compliant sequence for EDC system setup and implementation begins only after the study protocol is finalized, as all case report form (CRF) designs, database structures, and validation rules derive directly from the finalized protocol.
According to GCDMP (Chapter: EDC Systems Implementation), the proper order is:
Protocol finalized - defines endpoints and data requirements.
Database created - built according to the protocol and CRFs.
Edit checks created - programmed to validate data entry accuracy.
Database tested (UAT) - ensures functionality, integrity, and compliance.
Sites trained and system released - only then can data entry begin.
Option B follows this logical and regulatory-compliant sequence. Other options (A, C, D) are either paper-based workflows or violate GCP-compliant timelines (e.g., enrolling subjects before database validation).
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Electronic Data Capture (EDC) Systems, Section 5.2 - System Setup and Implementation Flow ICH E6(R2) GCP, Section 5.5.3 - Computerized Systems Validation and User Training Before Use FDA 21 CFR Part 11 - Validation and System Release Requirements
NEW QUESTION # 84
A Data Manager is establishing a timeline for database lock for a 100-person study where the data have been maintained almost all clean throughout the study. All data from external labs have been received and reconciled. Which is the best estimate of the amount of time needed to lock the database after Last Patient Last Visit?
- A. A few months
- B. A few days
- C. A few weeks
- D. A few hours
Answer: B
Explanation:
For a well-maintained 100-subject study with ongoing data cleaning and completed reconciliations, the database lock process typically takes a few days after the Last Patient Last Visit (LPLV).
According to the GCDMP (Chapter: Database Lock and Archiving), the duration of the lock process depends on the level of data cleanliness at LPLV. If the study team has conducted continuous data cleaning, query resolution, and external data reconciliation throughout the trial, then the final lock steps (e.g., final data review, documentation, and approvals) can be completed in 2-5 days.
However, if significant cleaning or reconciliation remains outstanding, lock may take several weeks. Since the question states that data are "maintained almost all clean," Option B - a few days - is the appropriate estimate.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Database Lock and Archiving, Section 6.2 - Database Lock Preparation and Timelines ICH E6 (R2) Good Clinical Practice, Section 5.5.3 - Data Quality and Lock Procedures FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Data Lock and Archiving Procedures
NEW QUESTION # 85
What action should be taken regarding the clinical database when MedDRA releases a new version of its dictionary?
- A. Identify an alternative dictionary.
- B. Continue using the existing version to code.
- C. Evaluate the extent and impact of the changes.
- D. Upgrade the version immediately and recode.
Answer: C
Explanation:
When a new version of MedDRA (Medical Dictionary for Regulatory Activities) is released, the correct action is to evaluate the extent and impact of the changes before implementation.
According to the GCDMP (Chapter: Medical Coding and Dictionaries), MedDRA updates are published twice yearly (March and September). Each release may introduce new terms, modify hierarchies, or retire old ones. Prior to adopting a new version, the Data Manager and Medical Coder must:
Assess the number and type of term changes,
Determine the potential effect on ongoing coding consistency, and
Decide whether migration to the new version is warranted mid-study or deferred until database lock.
Immediate recoding (option C) without evaluation may cause inconsistencies and require additional validation. Continuing with the existing version (option B) may be acceptable short-term but must be justified. Using an alternative dictionary (option D) is noncompliant, as MedDRA is the regulatory standard for safety reporting.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Medical Coding and Dictionaries, Section 6.3 - Version Control and Impact Assessment MedDRA Term Selection: Points to Consider (MSSO, Latest Version), Section 3 - Versioning and Maintenance ICH E2B(R3) - Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports
NEW QUESTION # 86
When reviewing local lab data from a paper study, a Data Manager notices there are lab values not entered. What should the Data Manager request data-entry personnel do?
- A. Nothing
- B. Flag the module for review
- C. Issue a query
- D. Call the patient to verify the information
Answer: C
Explanation:
When laboratory data are missing from a paper-based clinical study, the Data Manager should direct data-entry personnel to issue a query to the investigative site for clarification or correction.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Data Validation and Cleaning), every missing, inconsistent, or out-of-range data point must be reviewed and, if necessary, resolved through the formal query management process. This ensures that all discrepancies between the source documents and database entries are properly documented, traceable, and auditable.
Data-entry staff are not authorized to infer or fill in missing information. They must escalate such discrepancies to the site via query, preserving data integrity and regulatory compliance with ICH E6 (R2) and FDA 21 CFR Part 11. Calling the patient directly (option B) would violate confidentiality and site communication protocol, while simply flagging or ignoring the issue (options A and D) would not meet GCDMP query resolution standards.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Validation and Cleaning, Section 5.2 - Query Management and Resolution ICH E6 (R2) Good Clinical Practice, Section 5.18.4 - Communication of Data Discrepancies FDA 21 CFR Part 11 - Electronic Records; Query Audit Trails Requirements
NEW QUESTION # 87
Which database table structure is most appropriate for vital signs data collected at every-other visit for each patient in a study?
- A. One record per visit
- B. One record per patient
- C. One record per patient per visit
- D. One record per patient per study
Answer: C
Explanation:
In a relational clinical database, the most efficient and normalized structure for data collected repeatedly over time-such as vital signs-is one record per patient per visit.
Each patient will have multiple records, one for each visit when vital signs are assessed. This structure supports:
Time-based analysis (e.g., trends across visits),
Accurate data linkage with visit-level metadata, and
Efficient querying for longitudinal data.
According to the GCDMP (Chapter: Database Design and Build), the relational design principle dictates that data should be stored at the lowest unique level of observation. Since vital signs vary by both patient and visit, the combination of patient ID + visit ID forms a unique key for each record.
Option A (per visit) lacks patient identification, while options B and D aggregate data too broadly, losing temporal detail.
Thus, option C (One record per patient per visit) correctly represents the normalized design structure.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Database Design and Build, Section 4.2 - Normalization and Table Structure CDISC SDTM Implementation Guide, Section 5.3 - Visit-Level and Observation-Level Data Structures ICH E6(R2) GCP, Section 5.5.3 - Data Handling Principles
NEW QUESTION # 88
The result set from the query below would be which of the following?
SELECT Pt_ID, MRN, SSN FROM patient
- A. Wider than the patient table
- B. Narrower than the patient table
- C. Shorter than the patient table
- D. Longer than the patient table
Answer: B
Explanation:
In a SQL (Structured Query Language) database, the SELECT statement specifies which columns to display from a table. In this query, only three columns - Pt_ID, MRN, and SSN - are being selected from the patient table.
This means the resulting dataset will contain:
The same number of rows (records) as the original table (assuming no WHERE filter), and Fewer columns than the full table.
In database terminology:
"Wider" refers to more columns (fields).
"Narrower" refers to fewer columns (fields).
Since this query retrieves only 3 columns (out of potentially many in the original table), the result set is narrower than the patient table, making option D correct.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Database Design and Build, Section 5.1 - Relational Databases and Query Logic ICH E6(R2) GCP, Section 5.5.3 - Data Retrieval and Integrity Principles FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.4 - Database Query Controls
NEW QUESTION # 89
Which is the best way to see site variability in eligibility screening?
- A. Plot eligibility rate by site
- B. Summarize screening rate by site
- C. Graph enrollment by site
- D. List eligibility waivers by site
Answer: A
Explanation:
To identify site variability in eligibility screening, the most effective approach is to plot eligibility rate by site. This allows visual detection of differences in how well each site screens subjects according to protocol-defined inclusion and exclusion criteria.
The GCDMP (Chapter: Data Quality Assurance and Metrics) emphasizes the importance of graphical analysis for identifying anomalies and site-level performance variability. By plotting the eligibility rate by site, data managers and clinical operations teams can quickly identify outliers-sites that screen too many or too few eligible subjects-indicating potential training issues, misunderstanding of inclusion/exclusion criteria, or even possible protocol deviations.
While summarizing screening rate (B) provides useful numeric data, it lacks visual comparability. Listing waivers (A) or enrollment counts (C) provide limited insights into eligibility consistency.
Therefore, option D-Plot eligibility rate by site-is the best analytic and visualization practice to assess site variability in screening outcomes.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Quality Assurance and Control, Section 6.1 - Use of Metrics and Graphical Review for Site Performance ICH E6(R2) GCP, Section 5.18.4 - Identification of Systematic or Site-Specific Issues
NEW QUESTION # 90
A Data Manager receives an audit finding of three different instances of simultaneous log-ins to the EDC system by the same site user. This was observed at three different sites. Which of the following is the best long-term response to the audit finding?
- A. Acquiring technical controls from the same or a different system vendor that prevent simultaneous log-ins from the same user
- B. Requesting that the sites fire the offending users for a HIPAA violation and increasing the monitoring for the offending sites
- C. Refresher training for the offending users, re-communication of the binding nature of e-signatures to all users, routine monitoring for simultaneous log-ins from the same user
- D. Removing all access to the system until the situation is resolved
Answer: C
Explanation:
The best long-term corrective and preventive action (CAPA) in this situation is a combination of user re-training, communication, and routine monitoring - as described in Option B.
According to the GCDMP (Chapter: Electronic Data Capture Systems) and FDA 21 CFR Part 11, user credentials and electronic signatures in clinical systems are legally binding and must be used only by the assigned individual. Simultaneous log-ins under the same credentials often indicate credential sharing, a compliance violation that must be addressed through user education, reinforced security policies, and ongoing system oversight.
While technical controls (option A) may be considered, behavioral and procedural reinforcement are the first lines of defense. Options C and D are excessive and not aligned with proportional CAPA practices.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Electronic Data Capture (EDC) Systems, Section 7.1 - User Access, Authentication, and Training FDA 21 CFR Part 11 - Electronic Records and Electronic Signatures, Sections 11.10(i) and 11.200(a) ICH E6 (R2) Good Clinical Practice, Section 5.5.3 - Access Control and Audit Trail Requirements
NEW QUESTION # 91
It has been identified that ten adverse events were not reported in the trial prior to the database lock. What action should be taken to determine the next step?
- A. Check the data from all sites again before relocking the database.
- B. Notify upper management immediately so the monitor can contact the site.
- C. Evaluate the potential effect of the omission on the validity of the safety and efficacy analysis.
- D. Get the AE data entered immediately so the database can be locked again.
Answer: C
Explanation:
When adverse events (AEs) are discovered after a database lock, the appropriate first step is to evaluate the impact of the missing data on the integrity, safety analysis, and regulatory validity of the study results.
According to GCDMP (Chapter: Data Quality Assurance and Control), any post-lock data discovery requires a root cause assessment and impact analysis before deciding whether to unlock the database. The key question is whether the missing AEs:
Affect primary safety endpoints,
Introduce bias in safety reporting, or
Alter efficacy conclusions.
Based on the assessment, the Data Management and Biostatistics teams determine if unlocking and correction are justified. Simply entering data immediately (A) or repeating checks (D) without analysis may violate data control procedures.
Hence, option B is correct - the first step is to assess the impact on data validity and analysis.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Quality Assurance and Control, Section 5.5 - Post-Lock Findings and Impact Assessment ICH E6(R2) GCP, Section 5.1.1 - Quality Management and Risk Assessment FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.5 - Post-Lock Data Management
NEW QUESTION # 92
Which competency is necessary for EDC system use in a study using the medical record as the source?
- A. Screening study subjects
- B. Using ePRO devices
- C. Resolving discrepant data
- D. Training on how to log into Medical Records system
Answer: D
Explanation:
In studies where the medical record serves as the source document, the Electronic Data Capture (EDC) system users (typically study coordinators or site personnel) must have appropriate training on how to access and log into the medical record system. This competency ensures that data abstracted from the electronic medical record (EMR) are complete, accurate, and verifiable in compliance with Good Clinical Practice (GCP) and Good Clinical Data Management Practices (GCDMP).
According to the GCDMP (Chapter: EDC Systems and Data Capture) and ICH E6(R2), all personnel involved in data entry and verification must be trained in both the EDC and the primary source systems (e.g., EMR). This ensures that the integrity of data flow-from source to EDC-is maintained, and that personnel understand system access controls, audit trails, and proper documentation of source verification.
While resolving discrepant data (C) and screening subjects (A) are part of study operations, the competency directly related to EDC system use in EMR-based studies is the ability to properly log into and navigate the medical records system to extract source data.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Electronic Data Capture (EDC), Section 5.1 - Source Data and System Access Requirements ICH E6(R2) Good Clinical Practice, Section 4.9 - Source Documents and Data Handling FDA Guidance: Use of Electronic Health Record Data in Clinical Investigations, Section 3 - Investigator Responsibilities
NEW QUESTION # 93
Which metrics report listed below would best help identify trends in the clinical data?
- A. Last patient/last visit date to data lock date
- B. Percent of data/visits cleaned
- C. Number of subjects screened/enrolled
- D. Query frequency counts per data element
Answer: D
Explanation:
The Query frequency counts per data element (Option D) is the best metric for identifying data trends and potential systemic data issues in clinical trials.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Data Quality Assurance and Control), trend analysis involves identifying recurring data issues across subjects, sites, or variables to detect training gaps, protocol misinterpretation, or CRF design flaws. A high number of queries generated for specific fields (e.g., visit date, lab values, or dosing information) may indicate systemic problems such as unclear CRF instructions or site-level misunderstandings.
While metrics such as percent of data cleaned (A) and time to database lock (B) reflect overall progress and efficiency, they do not identify specific data pattern issues. The number of subjects screened/enrolled (C) pertains to recruitment rather than data quality.
Therefore, query frequency per data element provides actionable insights for quality improvement, process refinement, and early identification of potential risks.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 6.3 - Metrics and Trend Analysis ICH E6 (R2) Good Clinical Practice, Section 5.18.4 - Risk-Based Quality Review and Data Trends FDA Guidance for Industry: Oversight of Clinical Investigations - Risk-Based Monitoring, Section 6 - Data Metrics and Trend Evaluation
NEW QUESTION # 94
Which is the most important reason for why a data manager would review data before a monitor reviews it?
- A. Data can be viewed and discrepancies highlighted prior to a monitor's review.
- B. Data managers have access to programming tools to identify discrepancies.
- C. Data managers write the Data Management Plan that specifies the data cleaning workflow.
- D. The GCDMP recommends that data managers review data prior to a monitor's review.
Answer: A
Explanation:
The primary reason data managers review data before a monitor's review is to identify and flag discrepancies or inconsistencies so that site monitors can focus their efforts more efficiently during on-site or remote source data verification (SDV).
According to the Good Clinical Data Management Practices (GCDMP, Chapter on Data Validation and Cleaning), proactive data review by data management staff ensures data completeness and accuracy by identifying missing, inconsistent, or out-of-range values. This pre-review helps streamline the monitoring process, reduces the volume of open queries, and enhances data quality.
Option A is true but not the main reason for pre-monitor review. Option C highlights a capability rather than a rationale. Option D is partially correct, but the GCDMP emphasizes process purpose, not prescriptive order. Thus, option B correctly captures the practical and process-oriented reason for early data review-to ensure data are ready and accurate for the monitor's review phase.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 5.3 - Data Review Timing and Purpose ICH E6(R2) GCP, Section 5.18 - Monitoring and Data Verification Requirements
NEW QUESTION # 95
Which Clinical Study Report section would be most useful for a Data Manager to review?
- A. Rationale for the study design
- B. Clinical narratives of adverse events
- C. Description of statistical analysis methods
- D. Description of how data were processed
Answer: D
Explanation:
The section of the Clinical Study Report (CSR) most useful for a Data Manager is the description of how data were processed.
According to the GCDMP (Chapter: Data Quality Assurance and Control), this section details the data handling methodology - including data cleaning, coding, transformation, and derivation procedures - all of which are core responsibilities of data management. Reviewing this section ensures that the data processing methods documented in the CSR align with the Data Management Plan (DMP), Data Validation Plan (DVP), and database specifications.
The statistical methods section (option A) is primarily for biostatistics, and the rationale for study design (option B) pertains to clinical and regulatory affairs. Clinical narratives (option D) are used by medical reviewers, not data managers.
By reviewing how data were processed, the Data Manager verifies that the study data lifecycle-from collection to analysis-was conducted in compliance with regulatory and GCDMP standards.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Quality Assurance and Control, Section 6.3 - Documentation of Data Processing in Clinical Study Reports ICH E3 - Structure and Content of Clinical Study Reports, Section 11.3 - Data Handling and Processing FDA Guidance for Industry: Clinical Study Reports and Data Submission - Data Traceability and Handling Documentation
NEW QUESTION # 96
Which information should an auditee expect prior to an audit?
- A. Standard operating procedures
- B. Auditor's credentials and certification number
- C. Audit plan or agenda
- D. Corrective action requests
Answer: C
Explanation:
Prior to an audit, the auditee should expect to receive an audit plan or agenda, which outlines the scope, objectives, schedule, and logistics of the audit.
According to the GCDMP (Chapter: Quality Assurance and Audits), an audit plan ensures transparency, preparation, and efficient execution. It typically includes details such as:
The audit scope and objectives,
The audit team members,
Documents or processes to be reviewed, and
The audit schedule and timeframe.
This allows the auditee to prepare the necessary records, staff, and facilities. While the auditor's credentials (option A) may be shared informally, they are not a regulatory requirement. Corrective actions (option B) are outcomes of the audit, not pre-audit materials. Standard Operating Procedures (option C) may be requested during the audit but are not provided in advance.
Thus, Option D - Audit Plan or Agenda - is the correct and compliant answer.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Quality Assurance and Audits, Section 6.1 - Pre-Audit Planning and Communication ICH E6 (R2) Good Clinical Practice, Section 5.19.3 - Audit Procedures and Responsibilities FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations - Section 8.1 - Audit Preparation and Planning
NEW QUESTION # 97
......
SCDM CCDM Exam Syllabus Topics:
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
| Topic 5 |
|
Free CCDM Test Questions Real Practice Test Questions: https://interfacett.braindumpquiz.com/CCDM-exam-material.html